“Das PSMA-PET/CT soll bei allen Patienten mit biochemischem Progress nach radikaler Prostatektomie für eine frühe Tumordetektion eingesetzt werden.”
Authors:
- 5 June 2018
- journal article
- research article
- Published by Georg Thieme Verlag KG in Nuklearmedizin-Nuclear Medicine
- Vol. 57 (03) , 69-73
Abstract
Zusammenfassung: Die Debatte stellt die bekannte Evidenz zur Frage der PSMA-PET/CT beim biochemischen Rezidiv des Prostatakarzinoms dar und wägt interdisziplinär ab, in welcher Situation welcher Patient zur Wahl der adäquaten Therapieoption bildgebende Diagnostik erforderlich macht. Dabei werden grundsätzliche Überlegungen zur Versorgung onkologischer Patienten mit einbezogen.Keywords
This publication has 39 references indexed in Scilit:
- Systemic Radioligand Therapy with 177 Lu Labeled Prostate Specific Membrane Antigen Ligand for Imaging and Therapy in Patients with Metastatic Castration Resistant Prostate CancerJournal of Urology, 2016
- Elevated 68Ga Prostate-Specific Membrane Antigen Activity in Metastatic Non–Small Cell Lung CancerClinical Nuclear Medicine, 2016
- Initial Experience of 68Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical ProstatectomyEuropean Urology, 2016
- 68Ga-PSMA-HBED-CC PET for Differential Diagnosis of Suggestive Lung Lesions in Patients with Prostate CancerJournal of Nuclear Medicine, 2015
- Prostate-specific Membrane Antigen–radioguided Surgery for Metastatic Lymph Nodes in Prostate CancerEuropean Urology, 2015
- Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted TherapyJournal of Nuclear Medicine, 2015
- Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical ProstatectomyJournal of Nuclear Medicine, 2015
- Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2013
- Pelvic/Retroperitoneal Salvage Lymph Node Dissection for Patients Treated With Radical Prostatectomy With Biochemical Recurrence and Nodal Recurrence Detected by [11C]Choline Positron Emission Tomography/Computed TomographyEuropean Urology, 2011
- Long-Term Risk of Clinical Progression After Biochemical Recurrence Following Radical Prostatectomy: The Impact of Time from Surgery to RecurrenceEuropean Urology, 2011